{"schema_version":"secwatch.filing_event.v1","accession":"0001964738-25-000084","form_type":"8-K","ticker":"SOLV","cik":"0001964738","company_name":"Solventum Corp","filed_at":"2025-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.713098+00:00","generated_at":"2026-05-17T07:43:59.410837+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Solventum upsizes note tender offers to $2B, prices purchases at premiums","bullets":["Increased aggregate cap from $1.75B to $2B; Pool 1 max raised to $1.5B and Tender SubCap to $650M.","Financing condition (sale of purification/filtration business to Thermo Fisher) has been satisfied.","Accepted ~$650M of 5.450% 2027 notes (69.35% proration) and ~$797M of 5.400% 2029 notes (61.24% proration).","In Pool 2, accepted ~$458M of 6.000% 2064 notes and ~$22M of 5.900% 2054 notes (2.58% proration).","Total consideration includes $30 per $1,000 early tender payment; settlement expected Sept. 10, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001964738-25-000084","json":"https://secwatch.observer/filing/0001964738-25-000084.json","markdown":"https://secwatch.observer/filing/0001964738-25-000084.md","text":"https://secwatch.observer/filing/0001964738-25-000084.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1964738/000196473825000084/0001964738-25-000084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1964738/000196473825000084/solv-20250908.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:43:59.410837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}